SCHEMBL11078696

SCHEMBL11078696

CCOC(=O)C1(CCC2CCCC2)CO1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
ABCB11 O95342 1/20 0.43
LMNA P02545 1/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ATM Q13315 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
METAP2 P50579 1/20 0.35
CYP1A2 P05177 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
HSD11B1 P28845 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11070412 0.98 MAPT (0.42) MAPTABCB11LMNAMAPK1TDP1
SCHEMBL11073072 0.98 MAPT (0.42) MAPTABCB11LMNAMAPK1TDP1
SCHEMBL11077258 0.91 MAPT (0.47) MAPTABCB11LMNAMAPK1TDP1
SCHEMBL11067568 0.90 MAPT (0.46) MAPTABCB11LMNAMAPK1ATM
SCHEMBL11076786 0.90 MAPT (0.46) MAPTABCB11LMNAMAPK1ATM
SCHEMBL11073407 0.90 ABCB11 (0.49) MAPTABCB11LMNAMAPK1TDP1
SCHEMBL11075060 0.90 MAPT (0.46) MAPTABCB11LMNAMAPK1ATM
SCHEMBL11070127 0.90 MAPT (0.46) MAPTABCB11LMNAMAPK1ATM
SCHEMBL11080655 0.90 MAPT (0.46) MAPTABCB11LMNAMAPK1ATM
SCHEMBL11076754 0.88 ABCB11 (0.51) MAPTABCB11LMNAMAPK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4430339-A PROPHYLAXIS, METABOLISM, GLUCOSE, FATS, HYPOGLYCEMIC AGENTS BYK GULDEN LOMBERG CHEMISCHE FABRIK GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-02-07 US disclosed
WO-1982000822-A1 SUBSTITUTED OXIRANECARBOXYLIC ACIDS,THEIR PREPARATION AND THEIR USE AS MEDICAMENTS EISTETTER K 1982-03-18 WO disclosed